IL-6 is a pleotropic 26 kD protein that can act as both a pro-inflammatory cytokine and an anti-inflammatory myokine, a form of cytokine produced in muscle cells that participates in tissue regeneration and repair, maintenance of healthy bodily functioning, and homeostasis within the immune system. IL-6 plays a part in the immune, endocrine, nervous, and hematopoietic systems, in addition to bone metabolism, regulation of blood pressure and inflammation. Osteoblasts secrete IL-6 to stimulate osteoclast formation. Smooth muscle cells in the tunica media of many blood vessels also produce IL-6 as a pro-inflammatory cytokine. Furthermore, IL-6 is an important mediator of fever and of the acute phase response which is the body's rapid attempt to restore homeostasis after tissue injury, infection, neoplastic growth, or immunological disturbance. In addition, IL-6 can be released into circulation in response to various stimuli including PAMPs (pathogen-associated molecular patterns) and cortisol, a hormone produced by the human body under psychologically stressful conditions. In its role as an anti-inflammatory myokine, IL-6 precedes the appearance of other cytokines in the circulation, is notably elevated with exercise, and is mediated by both its inhibitory effects on TNF-α and IL-1, and activation of IL-1ra and IL-10. IL-6 signals through a cell-surface type I cytokine receptor complex formed by the binding of IL-6 to IL-6R, forming a binary complex, which in turn combines with GP130 to transduce extracellular signaling by the activation STAT3. Hence, it is thought that blocking the interaction between IL-6 and GP130 may have therapeutic potential via the inhibition of the IL-6/GP130/STAT3 signaling pathway. Moreover, IL-6 initiates the inflammatory and auto-immune processes in many diseases such as diabetes, atherosclerosis, depression, Alzheimer's disease, rheumatoid arthritis, cancer, and various others. Thus, there is an interest in the therapeutic potential of anti-IL-6 mAbs.
Protein Details
Purity
>97% by SDS-PAGE and analyzed by silver stain.
Endotoxin Level
<0.1 EU/µg as determined by the LAL method
Biological Activity
The biological activity of Mouse IL-6 was determined in a cell proliferation assay. The expected ED<sub>50</sub>=0.02-0.06 ng/ml.
Powered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments.
Recombinant Mouse IL-6 is widely used in research because it is a multifunctional cytokine essential for studying immune regulation, inflammation, hematopoiesis, and disease models in mice.
Key scientific reasons to use recombinant Mouse IL-6 in your research applications:
Immune Cell Differentiation and Function: IL-6 is critical for the differentiation of Th17 cells, memory B cells, plasma cells, and the reciprocal regulation of Th17 and Foxp3(+) Treg cells. It inhibits TGF-β-induced Foxp3 and induces RORγt, a Th17 lineage-specific transcription factor, making it indispensable for dissecting T cell lineage commitment and immune tolerance.
Inflammatory and Acute Phase Responses: IL-6 regulates acute phase reactions, inflammatory responses, and antigen-specific immune responses, making it a key molecule for modeling inflammation and immune activation in vitro and in vivo.
Hematopoiesis and Stem Cell Biology: IL-6 enhances hematopoietic stem cell proliferation and supports the expansion of progenitor cells, which is vital for studies on blood cell development and regenerative medicine.
Cell Proliferation and Bioassays: Recombinant Mouse IL-6 stimulates cell proliferation in specific cell lines (e.g., T1165.85.2.1 mouse plasmacytoma), making it useful for bioassays and functional studies of cytokine signaling.
Metabolic and Stress Responses: IL-6 acts as a stress hormone coordinating systemic immunometabolic reprogramming, including the regulation of glucose metabolism during acute stress, which is relevant for neuroimmunology and metabolic research.
Disease Modeling: IL-6 is implicated in the pathogenesis of autoimmune diseases, cancer, and chronic inflammatory conditions. Recombinant Mouse IL-6 is used to model these diseases, investigate cytokine signaling pathways, and test therapeutic interventions.
Standardization and Reproducibility: Using recombinant protein ensures consistent, defined activity and purity, which is crucial for reproducible experimental results and for standardizing protocols across studies.
Typical applications include:
In vitro cell culture assays to study immune cell activation, differentiation, and cytokine signaling.
In vivo mouse models to investigate the role of IL-6 in disease pathogenesis, immune regulation, and therapeutic targeting.
Functional bioassays to measure cytokine activity and downstream effects on target cells.
In summary, recombinant Mouse IL-6 is an essential tool for immunology, inflammation, hematopoiesis, and disease research due to its broad biological activities and relevance to mouse models.
Yes, recombinant mouse IL-6 can be used as a standard for quantification or calibration in ELISA assays, provided it is properly prepared and matched to your assay system.
Supporting details:
Recombinant mouse IL-6 is widely accepted as an ELISA standard for quantifying mouse IL-6 levels in various sample types, including serum, plasma, and cell culture supernatants.
Assay compatibility: Most commercial and custom ELISA kits for mouse IL-6 are validated to detect both natural and recombinant forms, and standard curves generated with recombinant IL-6 are parallel to those with native IL-6.
Preparation: For accurate quantification, reconstitute and dilute the recombinant IL-6 according to your assay protocol. Carrier proteins (e.g., BSA) may be recommended at concentrations of 5–10 mg/mL to stabilize the standard and prevent loss of activity. Always use the diluent specified by your kit or protocol to avoid matrix effects.
Calibration: Many ELISA kits calibrate their standards against international reference materials, such as the NIBSC non-WHO Reference Material (93/730), ensuring traceability and consistency.
Concentration range: Standard curves typically cover a range from high picogram to low nanogram per milliliter concentrations (e.g., 2000–15 pg/mL or 500–0 pg/mL), depending on assay sensitivity.
Best practices:
Confirm that your recombinant IL-6 is of high purity (≥95%) and low endotoxin content, as these factors can affect assay performance.
Validate that your antibodies (capture and detection) recognize recombinant IL-6 equivalently to native IL-6, especially if using custom assay components.
Include a standard curve on each plate for accurate quantification and to account for inter-assay variability.
Store recombinant IL-6 according to manufacturer recommendations, typically at ≤–20°C, and avoid repeated freeze-thaw cycles.
Limitations:
Use recombinant mouse IL-6 only for research purposes, not for diagnostic applications, unless specifically validated.
Do not use mouse IL-6 standards for quantifying IL-6 from other species, as cross-reactivity may be limited.
Summary: Recombinant mouse IL-6 is suitable and commonly used as a standard for ELISA quantification, provided it is prepared and handled according to best practices and assay-specific protocols.
Recombinant Mouse IL-6 has been validated for a broad range of applications in published research, primarily in vitro and in vivo functional assays, cell culture, and immunological studies.
Key validated applications include:
Cell proliferation assays: Used to stimulate proliferation of mouse B cell lines and plasmacytoma cell lines (e.g., T1165.85.2.1).
Bioassays: Widely used in functional bioassays to assess cytokine activity, including studies on T cell differentiation (e.g., Th17, Th9, Tfh), dendritic cell function, and hepatocyte expansion.
Colony formation assays: Induction of colony formation from hematopoietic progenitor cells in semi-solid medium.
Hybridoma preparation: Replacement of feeder cells in the generation of murine hybridomas.
In vitro differentiation: Used for differentiation of Th17 cells and other T cell subsets.
Retroviral transduction: Cultivation of bone marrow cells for retroviral transduction protocols.
ELISA standard: Used as a standard in ELISA assays for quantifying IL-6 levels.
Metabolic studies: Employed in metabolic research to model stress-induced hyperglycemia and hepatic gluconeogenesis in mice.
Osteoclastogenesis: Stimulation of osteoclast formation from precursor cells.
Acute phase response studies: Investigation of IL-6’s role in the acute phase response and inflammation.
Protein-protein interaction and binding assays: Used in binding and protein interaction studies.
Published research examples:
Studies on T cell subset differentiation and cytokine signaling (e.g., Th17, Th9, Tfh cells).
Investigation of IL-6’s role in tumor biology, chemoresistance, and immune modulation.
Research on metabolic adaptation to stress and glucose homeostasis in murine models.
Use as a standard in immunoassays such as ELISA for cytokine quantification.
Summary Table of Validated Applications
Application Type
Description/Use Case
Reference
Cell proliferation assays
B cell, plasmacytoma, hepatocyte expansion
Bioassays
T cell, dendritic cell, hepatocyte function
Colony formation
Hematopoietic progenitor cell colony induction
Hybridoma preparation
Feeder cell replacement
In vitro differentiation
Th17, Th9, Tfh cell differentiation
Retroviral transduction
Bone marrow cell cultivation
ELISA standard
Quantification of IL-6 in samples
Metabolic studies
Stress-induced hyperglycemia, gluconeogenesis
Osteoclastogenesis
Osteoclast formation from precursors
Acute phase response studies
Inflammation, immune response
Protein-protein interaction
Binding and interaction assays
These applications are supported by both product validation data and peer-reviewed publications, demonstrating the versatility of recombinant mouse IL-6 in immunology, hematology, oncology, and metabolic research.
To reconstitute and prepare Recombinant Mouse IL-6 protein for cell culture experiments, dissolve the lyophilized protein in sterile buffer to a concentration of 0.1–0.5 mg/mL, typically using sterile PBS with 0.1–1% carrier protein (such as BSA or HSA) to enhance stability and prevent adsorption to surfaces.
Detailed protocol:
Centrifuge the vial briefly before opening to ensure all lyophilized material is at the bottom.
Add sterile buffer: Reconstitute the protein at 0.1–0.5 mg/mL in sterile PBS or distilled water. For optimal stability, include at least 0.1%–1% BSA or HSA as a carrier protein.
Mix gently: Swirl or invert the vial gently until the protein is fully dissolved. Avoid vigorous vortexing to prevent denaturation.
Allow to equilibrate: Let the solution sit at room temperature for 5–10 minutes to ensure complete dissolution.
Aliquot and store: Divide into single-use aliquots to avoid repeated freeze-thaw cycles. Store at –20 °C or –80 °C for long-term storage; short-term storage (up to 1 month) can be at 2–8 °C under sterile conditions.
Working solution: Dilute the stock solution to the desired working concentration (typically in the range of 1–100 ng/mL for cell culture) using cell culture medium or buffer containing carrier protein.
Additional notes:
If the protein is supplied carrier-free, adding carrier protein during reconstitution is highly recommended to prevent loss due to adsorption.
Avoid repeated freeze-thaw cycles, as this can reduce protein activity.
Always use sterile technique to prevent contamination.
Example reconstitution (for 100 μg vial):
Add 1 mL sterile PBS + 0.1% BSA to obtain a 100 μg/mL stock solution.
This stock can then be further diluted in cell culture medium as needed for your experiments.
Summary of best practices:
Use sterile PBS or water with 0.1–1% BSA/HSA.
Reconstitute at 0.1–0.5 mg/mL.
Mix gently, aliquot, and store appropriately.
Dilute to working concentration in medium with carrier protein for cell culture use.
References & Citations
1. Febbraio, MA. and Pedersen, BK. (2005) Exerc Sport Sci Rev. 33(3):114-9.
2. Baier, M. et al. (1997) Proc Natl Acad Sci U S A. 94(10):5273-7.